Vivakor Secures $12M Convertible Note with 20% OID and Establishes $100M Equity Line, Featuring Highly Dilutive & Restrictive Terms

summarizeSummary

Vivakor has finalized a $12 million convertible note offering with a 20% original issuance discount and established a $100 million standby equity purchase agreement, both featuring terms highly unfavorable to existing shareholders and indicating severe financial distress.

check_boxKey Events

• Convertible Note Offering Finalized

  Vivakor closed the first $6 million tranche of a $12 million gross proceeds convertible note offering (total principal $15 million due to a 20% original issuance discount). The notes convert at the greater of $0.37 or 80% of the lowest 5-day VWAP, and include a 20% penalty on principal upon an event of default.

• Standby Equity Purchase Agreement (ELOC) Established

  The company entered into a $100 million equity line of credit, allowing it to sell shares at a discount (94% of lowest 3-day VWAP or 98% of lowest intraday price). A $250,000 facility fee is payable in shares for this commitment.

• Mandatory Dilution Mechanism

  A critical term mandates that if the stock price falls below $0.37 for five consecutive trading days, the company *must* draw the maximum amount from the ELOC and use at least 30% of the proceeds to repay the convertible notes, creating a significant "death spiral" risk.

• Restrictive Covenants Imposed

  The agreements include a "Most Favored Nation" clause and prohibit the company from issuing other variable rate transactions or equity-linked securities without investor consent, severely limiting future financing flexibility.

auto_awesomeAnalysis

This 8-K details the highly dilutive and restrictive terms of the $12 million convertible note offering and the $100 million standby equity purchase agreement (ELOC), which were previously announced. The 20% original issuance discount on the notes, combined with a variable conversion price (80% of lowest VWAP), ensures significant dilution for existing shareholders. The ELOC allows the company to sell shares at a discount to market prices. Most critically, the mandatory ELOC draw and note repayment mechanism, triggered if the stock falls below $0.37, creates a "death spiral" scenario where falling stock prices force further dilution. These terms, along with prohibitions on other equity sales and a "Most Favored Nation" clause, severely limit the company's financial flexibility. This capital raise, while providing a short-term lifeline, comes at an extremely high cost, underscoring the severe financial distress indicated by the company's recent going concern warning and Nasdaq compliance issues.